Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: A retrospective comparison

Stefania Redana, Michela Donadio, Franco Nolè, Maria E. Jacomuzzi, Alessandra Beano, Rossella Martinello, Anna Sapino, Giuseppe Viale, Massimo Aglietta, Filippo Montemurro

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: A retrospective comparison'. Together they form a unique fingerprint.

Medicine & Life Sciences